Farahani P. LACK OF HEALTH-RELATED QUALITY OF LIFE AND PATIENT-CENTRED OUTCOME MEASURES IN RANDOMIZED CONTROLLED TRIALS CONDUCTED FOR DIABETES PHARMACOTHERAPY: SGLT-2 RECEPTOR INHIBITORS AS AN EXAMPLE. J Popl Ther Clin Pharmacol [Internet]. 2018 Oct. 22 [cited 2024 Nov. 19];24(1). Available from: https://mail.jptcp.com/index.php/jptcp/article/view/132